1. Home
  2. CIGI vs RVMD Comparison

CIGI vs RVMD Comparison

Compare CIGI & RVMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Colliers International Group Inc. Subordinate Voting Shares

CIGI

Colliers International Group Inc. Subordinate Voting Shares

HOLD

Current Price

$102.44

Market Cap

5.5B

Sector

N/A

ML Signal

HOLD

Logo Revolution Medicines Inc.

RVMD

Revolution Medicines Inc.

HOLD

Current Price

$94.13

Market Cap

19.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CIGI
RVMD
Founded
1972
2014
Country
Canada
United States
Employees
N/A
883
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.5B
19.1B
IPO Year
1995
N/A

Fundamental Metrics

Financial Performance
Metric
CIGI
RVMD
Price
$102.44
$94.13
Analyst Decision
Buy
Strong Buy
Analyst Count
6
18
Target Price
$174.00
$117.33
AVG Volume (30 Days)
315.2K
1.6M
Earning Date
05-05-2026
05-06-2026
Dividend Yield
0.30%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$16.74
N/A
Revenue Next Year
$8.04
$408.69
P/E Ratio
$57.57
N/A
Revenue Growth
N/A
N/A
52 Week Low
$98.97
$29.17
52 Week High
$171.20
$124.49

Technical Indicators

Market Signals
Indicator
CIGI
RVMD
Relative Strength Index (RSI) 33.43 39.23
Support Level $98.97 $74.64
Resistance Level $149.12 $107.45
Average True Range (ATR) 3.81 3.20
MACD -0.16 -0.47
Stochastic Oscillator 17.11 10.06

Price Performance

Historical Comparison
CIGI
RVMD

About CIGI Colliers International Group Inc. Subordinate Voting Shares

Colliers International Group Inc provides commercial real estate professional services and investment management to corporate and institutional clients across different countries around the world. Its operating segments are Commercial Real Estate, Engineering and Investment Management. Maximum revenue for the company is generated from its Commercial Real Estate segment, which offers services like transaction and debt finance services, outsourcing in property management, valuation and advisory, loan servicing, and others. Geographically, the company generates maximum revenue from the United States followed by Canada, Euro currency countries, Australia, the United Kingdom, Poland, China, India, and other regions.

About RVMD Revolution Medicines Inc.

Revolution Medicines Inc is a clinical-stage precision oncology company developing novel targeted therapies for RAS-addicted cancers. The Company possesses structure-based drug discovery capabilities built upon chemical biology and cancer pharmacology know-how and proprietary technologies that enable the creation of small molecules tailored to unconventional binding sites. Its research and development pipeline comprises inhibitors that bind directly to RAS variants (RAS(ON) Inhibitors), designed to be used as monotherapy, in combination with other RAS(ON) Inhibitors and/or other therapeutic agents.

Share on Social Networks: